Comments on: Sosei Heptares Regains Full Ownership from GSK of HTL0027477, a Clinic-ready, First-in-Class Oral GPR35 Agonist for Inflammatory Bowel Disease

Comments on: Sosei Heptares Regains Full Ownership from GSK of HTL0027477, a Clinic-ready, First-in-Class Oral GPR35 Agonist for Inflammatory Bowel Disease https://insideout.vn/sosei-heptares-regains-full-ownership-from-gsk-of-htl0027477-a-clinic-ready-first-in-class-oral-gpr35-agonist-for-inflammatory-bowel-disease/ Inside Out Thu, 21 Mar 2024 00:01:00 +0000 hourly 1 https://wordpress.org/?v=6.6.2